Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Cryptos Facing a Possible Risk Reassessment

The evolving economic landscape and sentiment shifts may challenge the optimism around cryptos, prompting a risk reassessment.

7 Rock-Solid Dividend Stocks to Ride Out the Rest of 2023

Investors seeking shelter from market volatility are gravitating toward these dividend stocks to buy, enjoying both stability and income.

3 Gold Mining Stocks to Bet On as Market Fears Grow

As uncertainties rattle global economies, gold mining stocks are emerging as a beacon for investors seeking both security and growth.

3 Homebuilding Stocks to Skip as Sector Confidence Slides

As market dynamics shift, select homebuilding stocks are flashing caution signs, urging investors to reevaluate and act swiftly.

7 Tech Stocks to Buy as They Near 52-Week Lows

Although suffering from the market’s turbulence, these tech stocks to buy at 52-week lows just might surprise the Street.

7 Stocks That Could Soar Following the Fed’s Latest Decision

As the Fed's decisions echo through the market, these are the stocks to buy that could navigate the economic turbulence ahead.

Williams-Sonoma (WSM) Stock Just Hit a New 52-Week High

Williams-Sonoma just hit a new 52-week high, thanks in part to an investment firm’s support. That possibly bodes well for WSM stock.

U Stock Alert: Analysts Are Upbeat as Unity Adjusts Pricing Approach

With gaming development firm Unity Software making a U-turn on its unpopular policy, U stock looks more appealing to analysts.

Why Is TransCode Therapeutics (RNAZ) Stock Up 240% Today?

With TransCode Therapeutics delivering positive pre-clinical results for its brain tumor candidate, RNAZ stock soared on the implications.

MULN Stock Alert: What to Know as Mullen Receives EPA Certification

Although Mullen Automotive has once again delivered seemingly positive news, investors remain skeptical about MULN stock.